Invest1 publisherNot yet confirmed elsewhere3 min readPublished
Korea's delisting pause still locks shareholders out of eight stocks
Korea Exchange has deferred further delistings under its tougher market-cap rule, but trading stays suspended in eight companies it had already decided to delist. Their holders cannot sell, and the exchange's plan to challenge the ruling behind the pause leaves no date for trading to resume.
The Investor · Invest desk
What happened
- A Seoul court on Oct. 2 halted the delistings of Jooyeon Tech and KM Pharmaceutical until final rulings in their main cases.
- The court found the exchange had tightened the rules without giving companies an adequate opportunity to appeal.
- Minimums of 30 billion won for Kospi and 20 billion won for Kosdaq companies took effect in July, six months ahead of schedule.
- The next increase, to 50 billion won for Kospi and 30 billion won for Kosdaq, was pulled forward to January 2027, then postponed on Sept. 4 to July 2027.
- The court refused to suspend the administrative-issue designations themselves, so the criteria introduced in July stay in effect.
Compiled by The InvestorSomething wrong?How this is made
Why it matters
- cost Holders of the eight bear the cost: on a ceiling estimate, up to 180 billion won of stock that cannot be sold on the exchange and has no date to trade again.
- exposure The 60 designated companies that still trade are one delisting decision away from the same freeze once the deferral lifts, since the eight were suspended when their delistings were decided.
- constraint The pace of removals under the market-cap rule now depends on the courts, because the exchange has stopped new delistings while it challenges the ruling.
- decision The government has to decide whether the July 2027 step holds on a procedure a court has faulted; the exchange counted 94 Kosdaq companies under that step's 30 billion won minimum at end-2024.
Both companies that won the Oct. 2 injunctions, Jooyeon Tech and KM Pharmaceutical, are still among the eight stocks that cannot trade [3][7]. The exchange drew its line by date. Trading suspensions stay for any company whose delisting was decided before Oct. 2, and further procedures are deferred for the other companies designated over market-cap shortfalls [5].
An injunction protects the listing, or rather the company's claim to one, and a shareholder needs a bid. Pausing proceedings did not automatically restore trading, so holders of the eight cannot sell through normal stock trading [6]. Pintel and Gold&S had sought injunctions of their own before the ruling [16]. That puts half the frozen group in litigation [19].
The court's complaints were about process and speed. The 45-consecutive-day requirement it questioned replaced a test of 30 days within a 90-day window, including 10 in a row [9]. The consecutive run alone went up 4.5 times [20]. The court also flagged concerns over what a company must do to regain compliance, and said the rollout came too fast for companies to get ready [10]. The Financial Services Commission and the exchange unveiled the reforms on Feb. 12 [13]. On Kosdaq the minimum then went to 15 billion won in January and 20 billion won in July, up from 4 billion won at the end of 2025, a fivefold increase over seven months [14].
The Korea Herald report does not give the market value of the frozen shares, though the rule puts a ceiling on it. Two of the eight are on Kospi and six on Kosdaq [3]. If each sat at or under its market's July minimum when trading stopped, the frozen stock is worth at most 2 x 30 billion plus 6 x 20 billion won, or 180 billion won [23]. Of the 68 companies designated on these grounds, 21 on Kospi and 47 on Kosdaq [2][21], only those eight have had trading suspended [4].
Three outcomes are open for the eight. If the exchange wins its challenge, the delisting decisions can proceed. If the companies win their main cases, the decisions rest on a procedure a court has faulted. The third path, reopening the shares while litigation runs, is the one the exchange has excluded for now by keeping the pre-Oct. 2 suspensions [5]. The timing of any resumption is uncertain, according to the Korea Herald [18].
I think the frozen holders face a wait set by the exchange's appeal. The counter-case is that a final ruling in the main cases arrives first and settles the procedure question for all eight at once. The exchange has deferred only new procedures [1]. It has not lifted a suspension or withdrawn the July criteria [5][17]. This view is wrong if Jooyeon Tech or KM Pharmaceutical trades again before the appeal is decided.
What to watch
- Whether the exchange's challenge to the Oct. 2 injunctions succeeds, and whether trading in any of the eight resumes before it is decided.
- Rulings on the injunction requests filed by Pintel and Gold&S against their delisting decisions.
- Whether the July 2027 step to 50 billion won for Kospi and 30 billion won for Kosdaq holds or moves again.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence55
- Adoption
- Insufficient
- Hype gap0
- Incentives
- Insufficient
- Confidence60
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
The Korea Exchange said Wednesday it would defer further delisting procedures for companies designated as administrative issues for failing to meet minimum market capitalization requirements.
- [2]
As of Thursday, 21 Kospi-listed companies and 47 Kosdaq-listed companies had received the administrative-issue designation for failing minimum market capitalization requirements.
- [3]
Trading remains suspended for eight companies: Jooyeon Tech and SHD on the Kospi, and Silla SG, Gold&S, KM Pharmaceutical, Pintel, Sejin T&S and AFW on the Kosdaq.
- [4]
Unlike other companies designated as administrative issues that can continue trading, the eight had already received delisting decisions and had their trading suspended before the exchange announced the procedural suspension.
- [5]
The exchange said it would maintain existing trading suspensions for companies whose delistings had been decided before Oct. 2, while deferring further delisting procedures for other companies designated over market capitalization shortfalls.
- [6]
The suspension of further proceedings did not automatically restore trading for the eight companies, leaving their shareholders unable to sell their holdings through normal stock trading.
- [7]
The Seoul Southern District Court on Oct. 2 granted injunctions sought by Jooyeon Tech and KM Pharmaceutical, halting their delistings pending final rulings in the main cases.
- [8]
The court said the exchange had tightened the rules without giving companies an adequate opportunity to appeal.
- [9]
The court questioned the decision to extend the required period above the market capitalization threshold from 30 days within a 90-day window, including 10 consecutive days, to 45 consecutive trading days.
- [10]
The court raised concerns over the requirements for regaining compliance and said the accelerated rollout left companies too little time to prepare.
- [11]
New minimum market capitalization thresholds of 30 billion won for Kospi-listed companies and 20 billion won for Kosdaq-listed companies took effect in July, six months ahead of schedule.
- [12]
A further increase to 50 billion won for Kospi-listed and 30 billion won for Kosdaq-listed companies was brought forward from January 2028 to January 2027; on Sept. 4 the government postponed it to July 2027.
- [13]
The Financial Services Commission and the KRX unveiled the reforms on Feb. 12, bringing forward scheduled increases in minimum market capitalization thresholds.
- [14]
The minimum requirement for Kosdaq-listed companies rose fivefold in seven months, from 4 billion won at the end of 2025 to 15 billion won in January and 20 billion won in July.
- [15]
The exchange said 94 Kosdaq-listed companies had market capitalizations below 30 billion won at the end of 2024.
- [16]
Pintel and Gold&S had also sought injunctions against their delisting decisions before the Oct. 2 ruling.
- [17]
The court rejected requests to suspend the administrative-issue designations themselves; the designation criteria introduced in July will remain in effect.
- [18]
The exchange plans to challenge the ruling, leaving the timing of any resumption in trading uncertain for shareholders of the eight companies.
- [19]
Four of the eight suspended companies (Jooyeon Tech, KM Pharmaceutical, Pintel, Gold&S) have sought injunctions, half of the frozen group.
- [20]
The consecutive-day requirement rose from 10 days to 45 consecutive trading days, a 4.5-fold increase.
- [21]
68 companies in total carry the administrative-issue designation for market-cap shortfalls.
- [22]
60 of the 68 designated companies remain tradeable, outside the eight with suspended trading.
- [23]
Assuming each of the eight sat at or below its market's July minimum when trading stopped, the combined market value of the frozen stock is at most 180 billion won.
Sources
1 independent publisher whose own reporting we read for this story.
- koreaherald.comEight stocks remain frozen despite pause in delisting proceedings
1 article · October 9, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.
Entities
- Korea ExchangeFollow
- Financial Services Commission (Korea)Follow
- Seoul Southern District CourtFollow
- KOSPIFollow
- KOSDAQFollow
- Jooyeon TechFollow
- KM PharmaceuticalFollow
- PintelFollow
- Gold&SFollow